Estrella Immunopharma- Warrants (29/09/2028) Other Current Assets

As of the most recent data (June 2026), ESLAW shows a other current assets of $1.7M. That compares with $160K in the prior-year period — up 923.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ESLAW's other current assets is now $1.7M (was $160K) — a 923.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Estrella Immunopharma- Warrants (29/09/2028) is outperforming or lagging.

Tracking ESLAW's other current assets over time shows whether Estrella Immunopharma- Warrants (29/09/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7M That compares with $160K in the prior-year period — up 923.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Estrella Immunopharma- Warrants (29/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $1.7M) with ownership activity and broader fundamentals.